DNAJB12
Basic information
Region (hg38): 10:72332830-72355149
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DNAJB12 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 15 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 1 | 0 |
Variants in DNAJB12
This is a list of pathogenic ClinVar variants found in the DNAJB12 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-72336563-C-T | not specified | Uncertain significance (Mar 25, 2024) | ||
10-72336583-T-G | not specified | Uncertain significance (Nov 10, 2022) | ||
10-72336590-C-T | not specified | Uncertain significance (Apr 08, 2024) | ||
10-72336650-C-T | not specified | Uncertain significance (Oct 29, 2021) | ||
10-72336656-C-T | not specified | Likely benign (Mar 01, 2023) | ||
10-72336692-C-T | not specified | Uncertain significance (Oct 16, 2023) | ||
10-72338227-G-C | not specified | Uncertain significance (Dec 22, 2023) | ||
10-72340809-G-A | not specified | Uncertain significance (Apr 07, 2023) | ||
10-72340810-G-C | not specified | Uncertain significance (Nov 30, 2022) | ||
10-72340850-C-T | not specified | Uncertain significance (Mar 20, 2023) | ||
10-72340990-G-C | not specified | Uncertain significance (May 11, 2022) | ||
10-72341108-C-T | not specified | Uncertain significance (Jan 26, 2022) | ||
10-72345019-G-A | not specified | Uncertain significance (Jan 16, 2024) | ||
10-72345073-G-A | not specified | Uncertain significance (Dec 23, 2022) | ||
10-72354824-T-C | not specified | Uncertain significance (Jan 26, 2022) | ||
10-72354871-C-A | not specified | Uncertain significance (Sep 16, 2021) | ||
10-72354899-G-A | not specified | Uncertain significance (Aug 03, 2022) | ||
10-72354954-C-G | not specified | Uncertain significance (Oct 25, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DNAJB12 | protein_coding | protein_coding | ENST00000338820 | 8 | 22401 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.440 | 0.560 | 125730 | 0 | 18 | 125748 | 0.0000716 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.580 | 238 | 265 | 0.900 | 0.0000153 | 2663 |
Missense in Polyphen | 52 | 93.26 | 0.55758 | 1022 | ||
Synonymous | -0.179 | 114 | 112 | 1.02 | 0.00000694 | 832 |
Loss of Function | 3.13 | 4 | 18.5 | 0.216 | 9.68e-7 | 206 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000231 | 0.000210 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000352 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000229 | 0.000229 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a co-chaperone with HSPA8/Hsc70; required to promote protein folding and trafficking, prevent aggregation of client proteins, and promote unfolded proteins to endoplasmic reticulum-associated degradation (ERAD) pathway (PubMed:21150129, PubMed:21148293). Acts by determining HSPA8/Hsc70's ATPase and polypeptide-binding activities. Can also act independently of HSPA8/Hsc70: together with DNAJB14, acts as a chaperone that promotes maturation of potassium channels KCND2 and KCNH2 by stabilizing nascent channel subunits and assembling them into tetramers (PubMed:27916661). While stabilization of nascent channel proteins is dependent on HSPA8/Hsc70, the process of oligomerization of channel subunits is independent of HSPA8/Hsc70 (PubMed:27916661). When overexpressed, forms membranous structures together with DNAJB14 and HSPA8/Hsc70 within the nucleus; the role of these structures, named DJANGOs, is still unclear (PubMed:24732912). {ECO:0000269|PubMed:21148293, ECO:0000269|PubMed:21150129, ECO:0000269|PubMed:24732912, ECO:0000269|PubMed:27916661}.;
- Pathway
- Protein processing in endoplasmic reticulum - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.128
Intolerance Scores
- loftool
- 0.608
- rvis_EVS
- -0.11
- rvis_percentile_EVS
- 45.36
Haploinsufficiency Scores
- pHI
- 0.310
- hipred
- Y
- hipred_score
- 0.554
- ghis
- 0.583
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.802
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dnajb12
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- ubiquitin-dependent ERAD pathway;cellular protein-containing complex assembly;ERAD pathway;chaperone cofactor-dependent protein refolding;cellular response to misfolded protein
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;membrane;integral component of endoplasmic reticulum membrane;nuclear membrane
- Molecular function
- Hsp70 protein binding